<DOC>
	<DOCNO>NCT00243763</DOCNO>
	<brief_summary>The primary objective study determine maximum tolerate dose ( MTD ) , dose limit toxicity ( DLT ) , safety profile CHIR-258 administer subject refractory relapse multiple myeloma ( MM ) .</brief_summary>
	<brief_title>TKI258 Subjects With Refractory Relapsed Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Confirmed diagnosis multiple myeloma Evidence relapse refractory disease Intracranial disease epidural disease Clinically significant cardiac disease Diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Refractory Multiple Myeloma</keyword>
	<keyword>Relapsed Multiple Myeloma</keyword>
</DOC>